Analyzing the concept of independence in psychedelic research.
Katherine Cheung, Rebecca Ehrenkranz, Brian D. Earp, Edward Jacobs, David B. Yaden
Accountability in research May 1, 2026 DOI: 10.1080/08989621.2025.2601225 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Independence Conflicts of interest Objectivity |
| Key points | Argues that proposals for independent actors in research rely on an undefined concept of independence as freedom from biasing influences, and that trade-offs with other scientific desiderata, such as expertise, must be considered. |
Abstract
A number of proposals across different fields have suggested incorporating "independent" actors into the research process as a way to manage potential bias. For example, in response to allegations of bias in psychedelic science, some have suggested the idea of independent auditors for adverse events, as well as the incorporation of independent researchers into the research teams of psychedelic trials. However, despite growing interest in these methods, the concept of independence itself remains frequently undefined. Moreover, although introducing independent actors may seem like a prima facie beneficial solution to help reduce bias and improve the scientific rigor of research, it may come with significant drawbacks as well. Here, we argue that the sense of independence on which these proposals for independent actors implicitly rely on is freedom from any influence that might alter the actors' choices in a way that reduces the trustworthiness or accuracy of research findings. Whether it is possible to identify and involve such actors without incurring trade-offs with other scientific desiderata (e.g. due to the risk of inadequate expertise) is then further explored. We conclude by providing two models in law and science that may be helpful to draw upon if seeking to incorporate independent actors.
Citations in the library
Cites 14
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Long-lasting subjective effects of LSD in normal subjects Psychopharmacology September 16, 2017
- Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape JAMA Psychiatry March 29, 2023
and 9 more in the library